Redox Modulation of FAK Controls Melanoma Survival - Role of NOX4

Cristiane Ribeiro-Pereira; João Alfredo Moraes; Mariele de Jesus Souza; Francisco R. Laurindo; Maria Augusta Arruda; Christina Barja-Fidalgo

doi:10.1371/journal.pone.0099481

Abstract

Studies have demonstrated that reactive oxygen species (ROS) generated by NADPH oxidase are essential for melanoma proliferation and survival. However, the mechanisms by which NADPH oxidase regulates these effects are still unclear. In this work, we investigate the role of NADPH oxidase-derived ROS in the signaling events that coordinate melanoma cell survival. Using the highly metastatic human melanoma cell line MV3, we observed that pharmacological NADPH oxidase inhibition reduced melanoma viability and induced dramatic cellular shape changes. These effects were accompanied by actin cytoskeleton rearrangement, diminished FAK^Y397 phosphorylation, and decrease of FAK-actin and FAK-cSrc association, indicating disassembly of focal adhesion processes, a phenomenon that often results in anoikis. Accordingly, NADPH oxidase inhibition also enhanced hypodiploid DNA content, and caspase-3 activation, suggesting activation of the apoptotic machinery. NOX4 is likely to be involved in these effects, since silencing of NOX4 significantly inhibited basal ROS production, reduced FAK^Y397 phosphorylation and decreased tumor cell viability. Altogether, the results suggest that intracellular ROS generated by the NADPH oxidase, most likely NOX4, transmits cell survival signals on melanoma cells through the FAK pathway, maintaining adhesion contacts and cell viability.

Citation: Ribeiro-Pereira C, Moraes JA, Souza MdJ, Laurindo FR, Arruda MA, Barja-Fidalgo C (2014) Redox Modulation of FAK Controls Melanoma Survival - Role of NOX4. PLoS ONE 9(6): e99481. https://doi.org/10.1371/journal.pone.0099481

Editor: Masuko Ushio-Fukai, University of Illinois at Chicago, United States of America

Received: August 19, 2013; Accepted: May 15, 2014; Published: June 9, 2014

Copyright: © 2014 Ribeiro-Pereira et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported by CNPq (www.cnpq.br), CAPES (www.capes.gov.br), FAPERJ (www.faperj.br) and Sub-reitoria de Pós-Graduação e Pesquisa (SR-2/UERJ - www.sr2.uerj.br). M.A. Arruda is a L′Oréal-UNESCO-ABC For Women In Science National Fellowship – 2008 awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Melanoma arises from the malignant transformation of pigment-producing cells (melanocytes), and its incidence has increased in many countries, being a prominent worldwide public health challenge [1]–[3].

Development of skin cancer is a multistage process mediated by different cellular, biochemical and molecular changes, involving the activation of several anti-apoptotic and pro-survival signaling pathways. Though, a critical step in melanoma biology is its ability to overcome anchorage dependency, acquiring ‘vertical growth phase’ (VGP) properties, enabling these cells to enter the deeper dermis rather than growing only in or adjacent to the epidermis. VGP can therefore make melanoma cells competent to metastasis. The metastatic ability of these cells is closely related to a rearrangement on the integrin-coordinated signaling hierarchy [4], [5].

Epidemiological studies have demonstrated that the major risk factors for melanoma relate to both environmental exposure and genetic alterations. For example, melanoma incidence in white populations has revealed an inverse correlation with latitude and positive correlation with ultraviolet radiation (UVR) index [6]–[7]. Skin exposure to UVR generates ROS in excessive quantities [8]. However, rather than this occurring as a direct effect of UVR, it has been shown that the observed ROS accumulation also relies on ROS generated by highly specialized enzymatic systems [9].

ROS are classically referred as cytotoxic agents due to their ability to oxidize biomolecules [10]. However, the direct cell damage only occurs when their generation is greatly increased and the antioxidant mechanisms are overwhelmed, a condition defined as “oxidative stress” [11]. On the other hand, a growing body of reports shows that rather than being hazardous molecules, ROS are second messengers, able to modulate a number of signaling pathways, many of them involved in tumor development [12], [13].

Among all intracellular ROS-generating systems, the most specialized one is a family of multimeric enzymes called NADPH oxidase [14]. NADPH oxidase was primarily described in neutrophils where they exert a critical role in innate immunity, taking part in the killing of pathogens [15]. NADPH oxidase activity was also detected in other cell types, involving other homologous of the main membrane subunit, NOX. To date, five NOXs have been described (NOX1 – NOX5) [16].

In non-phagocytic cells, NADPH oxidase activity leads to the generation of ROS, which seems to modulate diverse intracellular signaling pathways [17], [18]. While in most cell types NADPH oxidase-dependent ROS generation is triggered and/or stimulated by agonists, many malignant cells constitutively produce ROS in an augmented fashion [19], [20]. Recent works have pointed to a critical role for ROS generated by NADPH oxidase in the initiation and progression phases of malignant cells development [21]–[24]. For example, NOX4 and NOX5 activities have been reported to be involved in the survival of human glioma, melanoma, and prostate cancer cells [25]–[27]. These findings suggest that the modulation of survival and proliferation signaling by ROS plays a critical role in cancer development. However, the mechanisms by which NADPH oxidase regulates these signaling pathways are not fully understood.

In this study, we aimed to characterize the role of endogenously produced ROS in MV3 cells, a highly aggressive human melanoma cell line [28]. Using both pharmacological and gene silencing approaches, we investigated the role of NADPH oxidase activity on cell fate and signaling. Our findings strongly suggest that constitutive NADPH oxidase activity stimulates FAK signaling pathway and protects melanoma cells from death. Furthermore, our data shed light on NOX4 as a novel pharmacological target for the control of melanoma growth and metastasis.

Material and Methods

Ethics Statement

Ethical approval was obtained from the Ethics Committee of Pedro Ernesto Hospital, Rio de Janeiro State University (2786/2010) and all volunteers gave written informed consent for participation before enrollment in the study.

Reagents

HEPES, ethylenediaminetetraacetate (EDTA), bovine serum albumin (BSA), penicillin, streptomycin, dihydrorhodamine 123 (DHR), phenylmethylsulfonyl fluoride (PMSF), benzamidine, leupeptin, and soybean trypsin inhibitor (SBTI), sodium orthovanadate (Na₃VO₄), apocynin (4-acetovanillone), 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenol tetrazolium bromide (MTT), pyrrolidine dithiocarbamate (PDTC), diphenyleneiodonium (DPI), TRITC-labelled phalloidin, cycloheximide (CHX), ribonuclease A (RNase A), propidium iodide (PI), diethylenetriamine pentaacetic acid (DTPA), RPMI-1640 medium, superoxide dismutase conjugated to polyethylene glycol (PEG-SOD), catalase conjugated to PEG (PEG-CAT) and sulforhodamine B were from Sigma-Aldrich (St. Louis, MO). Triton X-100, Percoll, PVDF membranes, Rainbow™ were from GE Healthcare (San Francisco, CA). Fetal bovine serum (FBS) was purchased from Cultilab (Campinas, SP, Brazil). Dulbecco's Modified Eagle Medium (DMEM), Dihydroethidium (DHE), anti- p-FAK397 and Lipofectamine 2000 were obtained from Invitrogen (Carlsbad, CA). DAF-FMDA, CM-H2DCFDA, HPF and JC-1 were obtained from Molecular Probes (Carlsbad, CA). siRNA oligomers for NOX4 (5′-CCTCAGCATCTGTTCTTAACCTCAA-3′) and its scrambled sequence (Scramble) were obtained using BLOCKiTTM RNAi Designer (Invitrogen). Antibody anti-caspase-3 was obtained from Cell Signaling. All other antibodies and protein A/G agarose were from Santa Cruz Biotechnology (Santa Cruz, CA). Streptavidin-conjugated FITC and Streptavidin-conjugated horseradish peroxidase were from Caltag Laboratories. ECL system (SuperSignal West Pico chemiluminescent substrate kit) was from Pierce Biotechnology (Rockford, IL, USA). High capacity cDNA reverse transcripition kit RNeasy, RNeasy Mini kit were from Qiagen, RQ1 RNase-Free DNase, the set of dN TP and RNasin RNase inhibitor were purchased from Promega (Madison, WI).

Cell Culture

MV3 human melanoma cell line [28] was a gift from Dr Cezary Marcienkiewicz (Center for Neurovirology and Cancer Biology, Temple University, PA, USA). MV3 cells were maintained in DMEM enriched with 10% FBS, 3.7 g/L sodium bicarbonate, 5.2 g/L HEPES, 0.5 U/mL penicillin and 0.5 mg/mL streptomycin at 37°C in a humidified atmosphere of 5% CO₂. Cells were grown to 80-90% confluence into 75 cm culture flasks and were detached by brief treatment with 5 mM EDTA in Hank's balanced salt solution (HBSS).

Measurement of ROS generation in intact cells by DHR

Intracellular ROS production by MV3 cells was measured by oxidation of dihydrorhodamine 123 (DHR) to rhodamine by H₂O₂ as previously described [29]. Briefly, MV3 cells were seeded on 96-well plates at a density of 6×10³ cells/well and, after overnight incubation, the medium was replaced by serum-free medium containing DHR (final concentration 50 µM). Cells were then washed with phosphate-buffered saline (PBS) before examination under an Olympus IX71 inverted microscope (Tokyo, Japan) equipped for fluorescence.

Cellular ROS measurement by HPLC

Ethidium and 2-hydroxyethidium (EOH), the oxidation products of DHE, were separated by HPLC as described above [30]. Briefly, human melanoma (4×10⁵ cells) cells were grown in 6-well dishes in DMEM medium supplemented with fetal bovine serum (10%). After adhesion, melanoma cells were incubated with DPI (10 µM) or SOD conjugated to polyethylene glycol (PEG-SOD, 25 U/mL), catalase conjugated to PEG (PEG-CAT, 200 U/mL), or both PEG-CAT (200 U/mL) and PEG-SOD (25 U/mL) for 1 hour at 37°C in a 5% CO₂ atmosphere. Cells were washed twice with Krebs (0.5 mM CaCl₂, 1.2 mM MgSO₄, 4.9 mM KCl, 5.7 KH₂PO₄, 145 mM NaCl, 5.7 mM Na₂HPO₄ and glucose 5.5 mM pH 7.4) and incubated in Krebs, containing DTPA (100 µM) at a final DHE concentration of 50 µM for additional 30 min. Cells were washed with Krebs, harvested in acetonitrile (0.5 mL/well) and centrifuged (12,000 g for 10 min at 4°C). Supernatants were dried under vacuum (Speed Vac Plus model SC-110A, Thermo Savant) and pellets maintained at −70°C in the dark until analysis. Samples were ressuspended in 60 µL in solution A (water/10% acetonitrile/0.1% trifluoracetic acid) and injected (50 µL) into HPLC system.

Real-time intracellular ROS production

MV3 melanoma cells (and MV3 cells silenced with siRNA scramble or siRNA NOX4, when mentioned) were detached by brief treatment with 5 mM EDTA in HBSS, collected by centrifugation, ressuspended in fresh 10% FBS DMEM medium and incubated overnight on 96-well black plates at a density of 6×10³ cells/well, at 37°C in a humidified atmosphere of 5% CO₂. The cells were washed three times with PBS, incubated in HBSS at 37°C, 5% CO₂ for 1 h. Cells were then loaded for 1 h with one of the intracellular ROS detection probes depicted below (final concentration 5 µM). Once loaded, cells were washed with PBS and treated or not with DPI. Fluorescence intensity was assessed throughout 3 h using in the microplate reader Envision™.

DAF-FM DA assay.

NO production was assessed by the fluorescence emitted by oxidized DAF, an specific probe for NO detection. Fluorescence was monitored at excitation and emission wavelengths of 495 nm and 515 nm, respectively.

CM-H2DCF DA assay.

ROS production was detected through fluorescence emitted from DCF oxidation. This probe detects ROS in general, being more selective to H2O2 and peroxynitrite. Fluorescence was monitored at excitation and emission wavelengths of 495 nm and 525 nm, respectively.

HPF assay.

Peroxynitrite (ONOO-) production was determined by monitoring the fluorescence resulted from HPF oxidation. This probe, which is selective for ONOO-, had its fluorescence detected at excitation and emission wavelengths of 490 nm and 515 nm, respectively.

Cell viability assays

MTT assay.

MV3 melanoma cells were detached by brief treatment with 5 mM EDTA in HBSS, collected by centrifugation, ressuspended in fresh 10% FBS medium DMEM and placed into 96-well plates at a density of 6×10³ cells/well. After adhesion, cells were incubated in the presence or absence of DPI (0.1–10 µM), Na₃VO₄ (0.1–3 µM), apocynin (1–10 µM) or PDTC (0.1–1 µM), at 37°C in humidified 5% CO₂. After 48 hours of incubation or after 48, 72 or 96 hours of siRNA transfection, MTT assay was performed as previously described [31]. Cells were incubated with MTT (50 µg/well) in the dark at 37°C for 4 hours, when MTT is reduced to formazan crystals by viable cells. After incubation, the formazan crystals were dissolved in isoprapanol and the optical densitometry obtained using a microplate reader (BIO-RAD) using a 570 nM filter. Results are shown as percentage of control, of three independent experiments performed in quintuplicate.

Sulforhodamine B assay.

MV3 melanoma cells were detached by brief treatment with 5 mM EDTA in HBSS, collected by centrifugation, ressuspended in fresh 10% FBS medium DMEM and placed into 96-well plates at a density of 6×10³ cells/well. After adhesion, cells were incubated in the presence or absence of DPI (10 µM), apocynin (10 µM) or cycloheximide (5 µM), at 37°C in humidified 5% CO₂. After 48 hours of incubation, or after 48, 72 or 96 hours of siRNA transfection, the medium was removed, and cells were fixed with cold 10% trichloracetic acid (TCA) for 1 hour at 4°C. Plates were washed 5 times with Milli-Q water and left to dry at room temperature. Cells were stained with 0.4% of sulforhodamine B (w/v) in 1% acetic acid (v/v) at room temperature for 10 minutes. sulforhodamine B was removed, and the plates were washed 5× with 1% acetic acid before air-drying. Bound dye was solubilized with 10 mM unbuffered Tris-base solution, and plates were left on a plate shaker for at least 10 minutes. Absorbance was measured in a 96-well plate reader (BIO-RAD), at 490 nm.

Immunocytochemistry and cytochemistry assays

For immunofluorescence microscopy, MV3 cells were grown on glass coverslips (9.0×10³ cells/well). After adhesion, MV3 melanoma cells were incubated in the presence or absence of DPI (10 µM) for 30 min, 2 and 4 h at 37°C and 5% CO₂ atmosphere. Following treatments, cells were washed with ice-cold PBS and fixed with PBS containing 4% paraformaldehyde/4% sucrose for 20 min at room temperature and permeabilized in PBS containing 0.2% Triton X-100 for 5 min. Then, cells were incubated with PBS-BSA for 30 min. For detection of FAK, permeabilized cells were incubated with anti-FAK antibody (1∶200) overnight at 4°C and then sequentially incubated with goat anti-IgG Ab biotin-conjugated for 1 h and streptavidin-conjugated FITC (1∶200) for 1 h. Filamentous actin was stained with rhodamin-conjugated phalloidin (1∶1000) for 2 h at room temperature. Coverlips were mounted onto microscope slides using a solution of 20 mM N-propylgallate and 20% glycerol in PBS. Microscopic analysis of FAK- and phalloidin-stained cells were carried out using a laser scanning confocal microscope (Olympus - Fluoview version 3.3).

Apoptosis detection

Hypodiploid DNA content analysis.

MV3 cells were detached by brief treatment with 5 mM EDTA in HBSS, collected by centrifugation and placed into 6-well plates at a density of 5×10⁵ cells/well in 10% FBS medium. After adhesion, melanoma cells were incubated in the presence or absence of DPI (10 µM), apocynin (10 µM) or cycloheximide (5 µM) for 24 h. Thereafter, cells detached with 5 mM EDTA in HBSS and collected by centrifugation were ressuspended in PBS, fixed with ethanol 70% for 2 h and incubated in PBS solution containing 200 µg/mL RNase A, 0.001% Triton X-100, 20 µg/mL PI for 30 min at room temperature. DNA contents in stained nuclei were analyzed with FACScan (Becton Dickinson). A suspension of cells was analyzed for each DNA histogram, and the percentage of cells in G0/G1, S, and G2/M phases was determined using the WINMDI program.

Experiments using RNA interference

NOX4 gene expression was repressed using RNA interference technology according to Lipofectamine 2000 manufacturer's protocol. MV3 cells were seeded in 6-well (2.5×10⁵/well, for western blotting or qRTPCR) or 96-well (5×10³, for ROS production kinectics analysis, MTT, sulforhodamine B and JC-1 assay plates. The transfection efficiency was determined with qRT-PCR and Western blotting.

Assessment of mitochondrial transmembrane potential (JC-1)

The mitochondrial stability was measured by the use of the cationic dye JC-1, which is incorporated to the mitochondrial intermembrane space. The monomer (green) can polymerize forming clusters known as J-aggregates (red) in a transmembrane potential-dependent manner. Therefore, viable, non-apoptotic cells exhibit a higher red/green ratio [32]. MV3 melanoma cells were seeded overnight into 96-well black plates at a density of 5×10³ cells/well. Cells were then, treated for 24 h with scramble siRNA or NOX4 siRNA. After that, cells were washed with PBS and stained with JC-1 (10 µg/mL) for 30 min. Mitochondrial transmembrane potential was monitored using Envision™ multilable plate reader. Red fluorescence intensity was assessed by excitation and emission at 560 nm and 595 nm, respectively and green fluorescence intensity was detected by excitation and emission at 485 nm and 535 nm, respectively. Mitochondrial transmembrane potential was expressed as the ratio red/green fluorescence.

Total cell extracts

After the incubation, the cells were suspended in lysis buffer (HEPES 20 mM, pH 7.9; glicerol 20% (v/v); NP-40 1% (v/v); MgCl₂ 1 mM; EDTA 0.5 mM; EGTA 0.1 mM; DTT 0.5 mM, Na₃VO₄ 1 mM) and the following protease inhibitors: PMSF (1 mM), aprotinin (2 µg/mL), leupeptin (2 µg/mL) and SBTI (2 µg/mL).

Immunoprecipitation

After adhesion, MV3 cells (5×10⁵ cells) were incubated in the presence or absence of DPI (10 µM) for 2 and 4 h at 37°C in a 5% CO₂ atmosphere. The cells were lysed with RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Sodium Desoxicolate w/v, EDTA 5 mM; 1% Triton X-100 v/v, 50 mM NaF, 1 mM Na₃VO₄, 30 mM Na₄P₂O₇, 10 mM Iodocetamide, 2 mM DTT) supplemented with the following protease inhibitors: PMSF (1 mM), aprotinin (2 µg/mL), leupeptin (2 µg/mL) and SBTI (2 µg/mL). Lysates were incubated for 2 h with polyclonal anti-FAK (1∶200) at 4°C in a rotatory shaker. After this time, protein A/G agarose (20 µL/mg protein) was added, and the samples were incubated overnight at 4°C. The content of FAK and cSrc were analyzed by Western Blotting, as described below.

Immunoblotting analysis

The total protein content in cell extracts was determined by BCA kit. Cell lysates were denatured in sample buffer (50 mM Tris-HCl, pH 6.8, 1% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue) and heated in a boiling water bath for 3 min. Samples (30 µg total protein) were resolved in 12% or 10% SDS-PAGE and proteins were transferred to PVDF membranes. Rainbow™ colored protein molecular weight markers were run in parallel in order to estimate molecular weights. Membranes were blocked with Tween-TBS (20 mM Tris, 0.5 M NaCl, pH 7.5, 0.1% Tween-20) containing 5% bovine serum albumin (BSA). Primary antibodies used in Western analysis were anti-FAK (1∶500); anti-phospho-FAK397 (1∶500), anti-caspase-3 (1∶500), anti-cSrc (1∶1000), anti-NOX4 (1∶1000), anti-NOX2 (anti-gp91phox; 1∶1000), anti-p22phox (1∶1000), anti-p40phox (1∶1000), anti-p47phox (1∶1000), anti-p67phox (1∶1000) and anti-βTubulin (1∶1000). The PVDF sheets were washed three times with Tween-PBS, followed by 1 h incubation with appropriate secondary antibody conjugated to biotin. Then, PVDF sheets were incubated with streptavidin-conjugated horseradish peroxidase (1∶10000) for 1 h and developed by an ECL system. The bands were quantified by densitometry, using Scion Image Software (Scion Co, Frederick, Maryland, USA).

Isolation of human neutrophils

Human neutrophils were isolated from 0.5% EDTA treated peripheral venous blood of healthy volunteers, using a four-step discontinuous Percoll gradient [33]. Erythrocytes were removed by hypotonic lysis. Isolated neutrophils (98% purity), estimated to be at least 96% viable by trypan blue dye exclusion, were ressuspended in RPMI-1640 medium.

RNA isolation and RT-PCR

Total RNA from MV3 melanoma cells (5×10⁵ cells), NGM melanocytes (were obtained by cell bank of Rio de Janeiro) (5×10⁵ cells) and human neutrophils (2×10⁶ cells) were isolated using RNeasy Mini kit. After DNase treatment (RQ1 RNase-Free DNase), the mRNA was reverse transcribed using high capacity cDNA reverse transcripition kit. Primers based on the sequence of human p47phox (GeneBank accession n° NM_000265). The following primers were used to amplify p47phox cDNA: sense, 5′ – ATGAGCCTGCCCACCAAGAT - 3′ (374–393), and antisense, 5′ – TCGAGGAAGGATGCTCCCAT - 3′ (683–702). The expected size of the p47phox PCR product was 328 bp. PCR was performed with the following parameters: 95°C for 5 min for 1 cycle and 32 cycles of denaturation at 95°C for 45 s, annealing at 58°C for 30 s, and elongation at 72°C for 30 s. The following primers were used to amplify NOX4 cDNA: sense, 5′ – TCACAGAAGGTTCCAAGCAG - 3′ (491–510), and antisense, 5′- CTGTATTTTCTCAGGCGTGC - 3′ (571–590). The expected size of the NOX4 PCR product was 91 bp. PCR was performed with the following parameters: One cycle of 95°C for 3 min followed by 35 cycles of denaturation at 95°C for 45 s, annealing at 59°C for 45 s, and elongation at 72°C for 30 s. GAPDH primers were used to validate the cDNA in each reaction. PCR products were separated by 2% agarose gel electrophoresis and visualized by UV exposure on transilluminator.

For qPCR assay the PCR products were obtained using a GeneAmo PCR System 2400 (Perkin Elmer). The Quantitative real time PCR was performed in a Rotor gene Q using a SYBR-green fluorescence quantification system (Qiagen) to quantify amplicons. The standard PCR conditions were 95° for 5 minutes, then 35 cycles at 95°C (5 s) and 60°C (10 s) followed by the standard denaturation curve. Before normalizing the values we performed ΔΔCT in function of actin gene expression.

Statistical analysis

Statistical significance was assessed by the two-tailed unpaired Student's t test. Data were log-transformed when required. Differences were considered statistically significant when p≤0.05. The data were analyzed using GraphPad Prism version 5.00 for Windows (GraphPad Software, USA).

Results

Constitutive ROS generation by MV3 melanoma cells requires NADPH oxidase activity

It has already been described that some melanoma cell lines can produce intracellular ROS in a NADPH oxidase-dependent manner [26]. We have observed, for the first time constitutive intracellular ROS generation by the human melanoma cell line MV3, using the dihydrorhodamine (DHR) assay. The non-fluorescent DHR is oxidized to the fluorescent rhodamine, indicating an intracellular accumulation of ROS (Fig. 1A). The fluorescence intensity dramatically diminished when cells were pre-incubated with the flavoprotein inhibitor DPI (10 µM; Fig. 1A), which selectively inhibits NADPH oxidase activity in the concentration range used in this study. Additionally, we have also assessed intracellular ROS generation monitoring dihydroethidium (DHE) conversion to ethidium. Results shown in Figure 1B suggest that superoxide and hydrogen peroxide are the major reactive oxygen species produced by MV3 cells, since the treatment with SOD and catalase impaired ethidium accumulation. Furthermore, the inhibition by DPI confirms that ROS generation by MV3 cells depends on NADPH oxidase activation (Fig. 1B).

Download:

Figure 1. Inhibition of NADPH oxidase activity abolishes intracellular ROS generation on melanoma cells MV3.

(A) After adhesion, melanoma cells were incubated with or without DPI (10 µM) for different times (0.5–3 h) and ROS generation was evaluated by dihydrorhodamine-123 (DHR) assay followed by fluorescence microscopy analysis. (B) MV3 cells were incubated for 1 h with DPI (10 µM), PEG-SOD (25 U/mL), PEG-CAT (200 U/mL), or PEG-CAT and PEG-SOD (200 U/mL, 25 U/mL, respectively). Cellular ROS production was measured by intracellular oxidation of DHE to ethidium assessed by HPLC. (C–E) MV3 cells were incubated with or without DPI (10 µM). Intracellular ROS production was measured by intracellular oxidation of CM-H2DCFDA (C), DAF-AM (D) or HPF (E), as described in Material and Methods. Data are expressed as mean ± SD of three independent experiments. * p<0.05 vs. control;

https://doi.org/10.1371/journal.pone.0099481.g001

In order to determine which ROS are constitutively produced by MV3 cells, we employed selective probes for different reactive oxygen and nitrogen species. MV3 cells constitutively produce considerable amounts of ROS, in a NADPH oxidase-dependent manner (Fig. 1C) and low amounts NO, which was DPI-insensitive (Fig. 1D). No detectable amounts of ONOO⁻ were generated by MV3 cells in basal conditions (Fig. 1E). These results strongly suggest that NADPH oxidase activity is the major source of ROS in resting MV3 melanoma cells.

NADPH oxidase-derived ROS are involved in MV3 melanoma cells survival

As observed in other melanoma cell lines [26], MV3 melanoma cells are highly sensitive to NADPH oxidase inhibition. DPI inhibits cell survival in a concentration-dependent manner, as assessed by MTT (Fig. 2A) and Sulforhodamine B (Fig. 2C) assays. However, apocynin, an inhibitor of the cytosolic subunit p47phox coupling to NOX2 [34] has no effect on MV3 survival (Fig. 2B and 2C), indicating that the production of ROS by MV3 cells is not related to NOX2 activity. Confirming the irrelevance of NOX2 in these effects, MV3 cells do not express p47phox, which is essential to NOX2 activity (Fig. 3A). We have also observed that MV3 cells express high levels of NOX4 mRNA (Fig. 3B). Furthermore, these melanoma cells do not express NOX5, another NADPH oxidase isoform, which does not depend on any of the classical cytosolic NADPH oxidase subunits and is present in endothelial cells (Fig. 3C). We also analyzed NOX subunits expression and we confirmed that MV3 expresses negligible levels of p40phox, p47phox, p67phox and NOX2 (components of the NOX2 NADPH oxidase complex). On the other hand, MV3 expresses NOX4 and p22phox (Fig. 3D). These results indicated that neither NOX2 nor NOX5 contribute for ROS production and strongly suggest that NOX4 is probably the major source of endogenous ROS in MV3 melanoma cell line.

Download:

Figure 2. Inhibition of NADPH oxidase activity reduces survival of human melanoma cells MV3.

(A–B) MV3 cells (6×10³) were incubated for 48 h with or without DPI (A; 0.1–10 µM) or apocynin (B; 1–10 µM), and MTT assay was performed as indicated in Material and Methods. (C) MV3 cells (6×10³) were incubated for 48 h with or without DPI (10 µM), apocynin (10 µM) or Cycloheximide (5 µM). Subsequently, sulforhodamine-B assay was performed as described in Materials and Methods. Results are shown as percentage of control and expressed as mean ± SD of at least three independent experiments performed in quintuplicate. *p<0.05 vs. control.

https://doi.org/10.1371/journal.pone.0099481.g002

Download:

Figure 3. Human melanoma cells MV3 express NOX4, but not NOX5 or NOX2-related NADPH oxidase subunits.

Total RNAs were extracted from MV3 melanoma cells and from human polymorphonuclear neutrophils (A–B, PMN), human melanocytes (B, NGM) or from a human microvasculature endothelial cells linage (C, HMEC-1), used as positive controls. The expression levels of p47phox (A), NOX4 (B) or NOX5 (C) were analyzed by RT-PCR, using GAPDH expression as internal control as described in Materials and Methods. (D) NOX4, NOX2, p22phox, p40phox, p47phox, p67phox and βTubulin protein expression were detected by western blotting as described in Materials and Methods. Data are expressed as mean ± SD of three independent experiments and images are representative of three independent experiments with similar results.

https://doi.org/10.1371/journal.pone.0099481.g003

NADPH oxidase regulates focal adhesions and actin cytoskeleton dynamics in MV3 melanoma cells

We had observed, during routine cell culture monitoring, that melanoma cells treated with DPI displayed severe morphological alterations in early time points, without affecting cell integrity (data not shown). We therefore investigated whether NADPH oxidase-derived ROS could play a role on actin cytoskeleton dynamics and focal adhesion stability in MV3 cells.

In control cell cultures filamentous actin (red) and FAK (green) can be found co-localized at the cell border as seen by the formation of false yellow dots (white arrows), conferring cell adhesion and stability (Fig. 4; control). The treatment with DPI (10 µM) reduced cell spreading and promoted actin network rearrangement since very early time points (Fig.4; 30 min). The yellow dots, representing actin and FAK co-localization, are no longer seen homogenously distributed along the cell edges after 30 min incubation with DPI, being more abundantly found in the cytosol, associated to the ends of actin stress fibers, which do not reach the periphery of the cell body. At extended incubation times (2h) actin assumes a cortical arrangement (blue arrows), FAK is dispersed in cytosol (green fluorescence), and there is a reduced number of focal adhesions.

Download:

Figure 4. NADPH oxidase regulates cytoskeleton dynamics and focal adhesion sites.

MV3 adherent cells were incubated with DPI (10 µM) for 0.5, 2 and 4 hours and double-stained for FAK (FITC, green) and F-actin (TRITC-phalloidin, red). Co-localization was recognized as yellow dots, as indicated by white arrows and F-actin cortical distribution indicated by blue arrows. Images were obtained with a laser scanning confocal microscope (100X). Images are representative of three independent experiments with similar results.

https://doi.org/10.1371/journal.pone.0099481.g004

After 4 h treatment, cells seem to be irreversibly committed to undergo apoptosis, presenting dramatic disruption of the actin cytoskeleton organization, which is accompanied by alterations in the normal cellular distribution of FAK. At this time point, FAK does not localize in focal adhesion-like structures, but abnormally accumulates at non-specialized sites of the cell membrane. Those alterations precede cell detachment and consequent cell death.

FAK^Y397 phosphorylation and its association to cSrc requires NADPH oxidase activity

Early studies have demonstrated that ROS can modulate integrin-mediated signaling, enhancing FAK autophosphorylation at Tyr397 [35], an essential step to FAK assembly to polymerized actin. Western blotting analysis showed that NADPH oxidase inhibition by DPI drastically reduces FAK phosphorylation (Fig. 5A). Moreover, treatment with DPI significantly reduced FAK-cSrc association (Figure 5B) without changing cSrc expression (Figure 5C).

Download:

Figure 5. Inhibition of NADPH oxidase activity reduces FAK^Y397 phosphorylation and FAK-Src association on human melanoma cells.

(A) DPI (10 µM) was added to adherent cells (MV3) for 2 hours. Afterwards, total extracts obtained and the content of FAK and FAK^Y397 was assessed by immunoblotting. Blots were analyzed by densitometry, and phospho-FAK^Y397/total FAK ratio content is expressed as arbitrary units. (B) After adhesion MV3 cells were incubated in the presence or absence of DPI (10 µM) for 2 hours. Cells were then harvested, lysed and cell extracts were immunoprecipitated with anti-FAK and Western blots were performed for FAK and cSrc detection. Blots were analyzed by densitometry, and cSrc/total FAK ratio content was expressed as arbitrary units. (C) DPI (10 µM) was added to adherent cells (MV3) for 2 hours. Afterwards, total extracts obtained and the content of cSrc and βTubulin was assessed by immunoblotting. Blots were analyzed by densitometry, and cSrc/βTubulin ratio content is expressed as arbitrary units. *p<0.05 vs. control. Images are representative of three independent experiments.

https://doi.org/10.1371/journal.pone.0099481.g005

NADPH oxidase inhibition induces apoptosis in melanoma cells

Treatment of MV3 melanoma cells with DPI induced procaspase-3 cleavage, a critical step to the generation of active caspase-3 (Fig. 6A). Cell cycle analysis performed with PI-stained cells shows that DPI significantly increased the percentage of hypodiploid cells, indicating apoptosis (Fig. 6B). DPI effect was comparable to the classical inductor of apoptosis, the protein synthesis inhibitor, cycloheximide. As MV3 melanoma cells, constitutively presents high expression of phosphatidylserine on outer cell membrane, it was not possible to detect cell apoptosis through fluorescent Annexin-V binding assay (data not shown).

Download:

Figure 6. Inhibition of NADPH oxidase activity induces apoptosis on human melanoma cells.

(A) After adhesion, MV3 cells were incubated in the presence or absence DPI (10 µM) or CHX (5 µM) for 18 h. Cells were lysed and cell extracts submitted to SDS-PAGE in order to detect procaspase-3 and cleaved caspases-3 content, which were then analyzed by densitometry. ERK served as a loading control. Data shown are representative of three independent experiments with similar results. (B) After adhesion, cells were incubated in the absence or in the presence of DPI (10 µM) or CHX (5 µM) for 24 h. Cells were then harvested, fixed and stained with PI. Flow cytometric analysis of DNA contents was determined using WINMDI software. Percentage of apoptotic (in sub-G0) cells are expressed as mean ± SD of three independent experiments. *p<0.05 vs. control.

https://doi.org/10.1371/journal.pone.0099481.g006

NOX4 silencing diminishes phosphorylated FAK content and MV3 cell survival

In order to confirm the involvement of NOX4 on the afore-mentioned events, MV3 melanoma cells were transiently transfected with NOX4 siRNA. The transfection promoted partial, but a highly significant decrease in NOX4 mRNA (Fig. 7A) and protein levels (Fig. 7B). Interestingly, we observed that the major source of basal ROS is NOX4, since its silencing significantly inhibited ROS accumulation in MV3 (Fig. 7C). Consistent with data obtained using NADPH oxidase pharmacological inhibition with DPI, NOX4 siRNA treatment decreased phosphorylated FAK content (Fig. 8A), as well as, induced the mitochondrial transmembrane potential dissipation (Fig. 8B), decreased pro-caspase 3 levels (Fig. 8C), and inhibition of MV3 survival at later time points (Fig. 8D, E).

Download:

Figure 7. NOX4 silencing reduces MV3 melanoma basal ROS production.

(A) Total mRNAs were extracted from the MV3 cells carrying scramble siRNA (Sc) or NOX4-specific siRNA (siRNA) and qRT-PCR was performed to analyze NOX4 mRNA expression, with actin as internal control as described in Materials and Methods. (B) Lysates obtained from transfected cells (10⁶ cells) were subjected to immunoblotting to detect NOX4. Data are expressed as mean ± SD of three independent experiments and images are representative of three independent experiments with similar results. *p<0.05 vs. Scramble. (C) ROS detection assay (CM-H₂DCFDA) was performed with MV3 melanoma cells transfected with Scramble or NOX4 siRNA, as described in Materials and Methods. Results are shown as percentage of Scramble of three independent experiments *p<0.05 vs. Scramble.

https://doi.org/10.1371/journal.pone.0099481.g007

Download:

Figure 8. NOX4 silencing reduces MV3 melanoma cell survival and FAK phosphorylation in MV3 melanoma cells.

Lysates obtained from transfected cells (10⁶ cells) were subjected to immunoblotting to detect phospho-FAK^Y397 (A) and caspase-3 (C). (A) Data are expressed as mean ± SD of three independent experiments and images are representative of three independent experiments with similar results. *p<0.05 vs. Scramble. (C) Data shown are representative of three independent experiments with similar results. JC-1 (B), Sulforhodamine-B (D) and MTT (E) assays were performed with MV3 melanoma cells transfected with Sc or siRNA as described in Materials and Methods and the results are shown as percentage of Scramble of three independent experiments *p<0.05 vs. Scramble.

https://doi.org/10.1371/journal.pone.0099481.g008

ROS can lead to a down-regulation of protein tyrosine phosphatases, indicating that the redox status of the intracellular environment may have major implications in cell signaling and fate [36]. In order to evaluate whether the effect of NADPH oxidase inhibition on melanoma viability relies on increased protein tyrosine phosphatase activity, MV3 cells were incubated with the protein tyrosine phosphatase inhibitor, Na₃VO₄, in the presence or in the absence of DPI. Na₃VO₄ had no impact on melanoma viability per se (data not shown), however, the pre-treatment with low concentrations of this compound prevented DPI-evoked cell death (Fig. S1), suggesting that intracellular ROS are probably interfering on FAK activity/phosphorylation through their effect on phosphatase activity, in MV3 cells.

Discussion

During the last few years, ROS have emerged as prominent signaling molecules, and seem to play a central role in key intracellular signal transduction pathways involved in a variety of cellular processes [37]. Aberrant ROS signaling may result in physiological and pathological changes, such as impaired or enhanced cell cycle progression and apoptosis [38], [39]. Furthermore, the maintenance of a pro-oxidant intracellular milieu was shown to be closely related to the establishment and development of a variety of cancers [40].

The involvement of ROS in all stages of cancer development was observed in many cell types [41], [42]. The accumulation of ROS may reflect ineffective antioxidant mechanisms and/or a super-activation of ROS-generating systems such as NADPH oxidase [43], [44]. A role for the NADPH oxidase system was reported in a malignant phenotype of prostate cancer cell [45], on the migration of breast cancer cells [46] and epithelial-mesenchymal transition in melanoma cells [22].

In this work, we show that MV3, a highly metastatic human melanoma cell line, also generates ROS in a NADPH oxidase-dependent manner. The inhibition of NADPH oxidase by DPI, a flavoprotein inhibitor that selectively targets NADPH oxidase in the concentration range used in this study, inhibited ROS production, what was followed by reduced cell survival, indicating a pivotal role of ROS produced by NADPH oxidase in MV3 cell survival. There is also strong evidence that DPI, under these experimental conditions, selectively inhibits NADPH oxidase activity, once it had no impact on NO and ONOO⁻ accumulation.

The NOX2 NADPH oxidase is well known as the main isoform responsible for the production of great amounts of ROS by phagocytes, but it is also found in a variety of non-phagocytic cell types, where it is mainly activated in response to agonists [47]. However, NOX4 stands apart from the rest of the family since it appears to be constitutively active, being primarily regulated by its level of expression and addressed as the main source of ROS in a number of melanoma cell lines [14], [26], [48]. The production of ROS by MV3 cells seems to rely mainly on the activity of NOX4, as we observed through NOX4 siRNA. The participation of NOX2 in NADPH oxidase-mediated effect was excluded once like other melanoma cell linage [26], MV3 cells do not express p47phox subunit (critical to NOX2-containing NADPH oxidase activation), and apocynin did not affect melanoma viability. On the other hand, MV3 cells express high levels of NOX4, which does not require coupling to any cytosolic subunit to be active.

Although the importance of NADPH oxidase-mediated signaling has been demonstrated in different malignant cells, the molecular targets of their products have not been fully elucidated. Previous works have suggested that the effects of the endogenous ROS would rely exclusively on classical pro-survival, redox-sensitive transcription factors, like NF-κB and AP-1 [26]. However, monitoring MV3 cell cultures treated with DPI since early time points (30 minutes) unveiled severe morphological changes that preceded any alteration in cell viability. Those changes provided a valuable clue, leading us to investigate signaling pathways involved in cell adhesion.

Focal adhesions are points of interaction between integrins and extracellular matrix (ECM) and draw together adhesion receptors, as well as signaling and cytoskeletal proteins. They are critical to maintaining cellular shape, survival, growth and migration [49]. The focal adhesion kinase is primarily activated during integrin-mediated cell adhesion to ECM and to a lesser extent by growth factors, bioactive lipids, neuropeptides, and ROS [35]. Autophosphorylation of FAK at Tyr397 residue induces its accumulation to focal adhesion complexes and establishes a close connection between integrins to actin cytoskeleton [50].

When MV3 melanoma cells are seeded on culture dishes, they form a monolayer firmly attached to the substrate, displaying focal adhesion points along the cell edge. However, NADPH oxidase inhibition promoted reduction in cellular spreading, collapsing focal adhesions cortical organization. Moreover, we observed the formation of cortical polymerized actin ring, an indicative of cell detachment.

As a key molecule in the transduction of integrin-mediated signaling, FAK is critically involved in the development and progression of cancer, regulating survival, proliferation, migration and invasion [51]. Not surprisingly, highly aggressive melanoma cell lines contained constitutive high levels of phosphorylated FAK whereas the poorly aggressive melanoma cell lines did not [52]. MV3 melanoma cell line is characterized as highly metastatic [28] and our results confirmed that this phenotype is linked to constitutive high levels of FAK phosphorylated on tyrosine 397.

The phosphorylation of FAK at Tyr397 creates a high-affinity binding site for the tyrosine kinase cSrc, which is then activated [53]. The FAK-Src complex mediates cell migration [54], proliferation [55] and survival [56]. Our data shows that high levels of FAK are constitutively associated to Src in MV3 melanoma cells. However, the inhibition of NADPH oxidase activity by DPI or NOX4 silencing significantly reduced FAK^Y397 phosphorylation and probably disrupted FAK-Src association. These results indicate once more that ROS derived from a NADPH oxidase, most likely NOX4, seems to modulate focal adhesion dynamics in MV3 cells. Supporting this premise, it has been reported a close relationship between NOX4 activity and focal adhesion formation, involving a novel p22phox binding partner (Poldip2), which stabilizes NOX4-p22phox complexes and increases NOX4 association to focal adhesions [57].

The ROS-induced protein tyrosine phosphorylation seems to rely on their ability to promote post-translational modification on tyrosine kinases and PTP, resulting in their activation and inactivation, respectively [35]. It has also been reported that oxidative inhibition of PTP is a critical step to FAK-mediated cell adhesion [34]. We observed that Na₃VO₄, a broad-spectrum PTP inhibitor, totally abolished DPI effect on cell growth (Fig. S1), suggesting that oxidation of PTPs by NADPH oxidase-derived ROS leads to impairment of FAK dephosphorylation and consequent maintenance of FAK-mediated signaling.

Focal contacts disorganization results in a specific form of apoptosis known as anoikis [58]. Studies have showed that resistance to anoikis seems to be involved in the onset and evolution of tumors, as well as in cell growth and metastatic potential [59]. FAK phosphorylation suppresses this specific form of apoptosis [60], whereas attenuation of FAK expression or inhibition of FAK increases apoptosis and suppresses metastasis in tumor cells [61], [62]. Furthermore, other studies have shown ROS involvement in anoikis resistance [63]–[65]. In this study, we noted that DPI-induced cell death seems to involve a significant increase in the hypodiploid population and caspase-3 activation, phenomena that follow a rapid alteration on focal adhesion dynamics, strongly suggesting apoptotic death. Corroborating the NOX4 relevance in MV3 melanoma cell survival, we also observed that NOX4 siRNA induced mitochondrial transmembrane potential dissipation, an early hallmark of apoptosis. Complementary experiments are needed in order to fully characterize the observed cell death as anoikis. We also investigated DPI-induced modulation of mitochondrial-derived ROS. DPI did not affect constitutive mitochondrial ROS production, as evaluated using the specific probe MitoSox (Fig. S2).

Taken together, our data strongly suggest that NADPH oxidase-derived ROS convey cell survival signals in MV3 melanoma cells through the persistent activation of the FAK pathway, probably inhibiting protein tyrosine phosphatase activity. Our study addresses, for the first time, FAK as an important target of ROS-mediated signaling in melanoma cells, showing that FAK phosphorylation and downstream events are highly sensitive to NADPH oxidase-derived ROS. NADPH oxidase inhibition promotes focal adhesions breakdown and cell death, (Fig. 9). These findings shed light on a still underappreciated face of ROS signaling in cancer cells and may corroborate to the development of more selective and effective strategies in order to control melanoma growth and metastatic colonization.

Download:

Figure 9. A schematic model for signaling pathway activated by NADPH oxidase-generated ROS on human melanoma cells.

NADPH oxidase-derived ROS down-modulate protein tyrosine phosphatases, consequently increasing FAK phosphorylation. FAK^Y397 phosphorylation creates a high-affinity site for cSrc, as well as stimulates actin polymerization and focal adhesion stabilization, positively modulating cell motility, proliferation and survival. NADPH oxidase inhibition by DPI or NOX4 siRNA reduces ROS production, what probably leads to an increased protein tyrosine phosphatase activity, which, in turn, could inhibit focal adhesion formation/stabilization and induce MV3 human melanoma cells death.

https://doi.org/10.1371/journal.pone.0099481.g009

Supporting Information

Figure S1.

Inhibition of tyrosine phosphatase activity reverts DPI effect on melanoma survival. Cells (6×10³) were preincubated for 30 min in the presence or absence of increasing concentrations of Na3VO4 (0.1–3 µM) and subsequently treated with DPI (10 µM) for 48 hours. MTT assay was performed as described. Results are shown as percentage of control and are expressed as mean ± SD of three independent experiments performed in quintuplicate. *p<0.05 vs. control, **p<0.05 vs. DPI.

https://doi.org/10.1371/journal.pone.0099481.s001

(TIF)

Figure S2.

Inhibition of NADPH oxidase activity does not abolish constitutive mitochondrial ROS generation on melanoma cells MV3. MV3 cells were incubated with or without DPI (10 µM). Mitochondrial ROS production was measured by MitoSox probe oxidation. Data are expressed as mean ± SD of six independent experiments. * p<0.05 vs. control.

https://doi.org/10.1371/journal.pone.0099481.s002

(TIF)

Acknowledgments

We would like to thank Genilson Rodrigues, Renata Turreta and Amanda Lima-Resende for their excellent technical support, Carlos Bizarro for confocal microscopy analysis, Denise Fernandes and Maria Aparecida Bertoline for cellular ROS measurement by HPLC. We would also want to express our gratitude to Mr. Andrew W. Bullock for kindly revising this manuscript.

Author Contributions

Conceived and designed the experiments: CRP MAA JAM. Performed the experiments: CRP JAM MJS. Analyzed the data: CRP JAM MAA. Contributed reagents/materials/analysis tools: CBF MAA FRL. Wrote the paper: CRP JAM.

References

1. Chin L (2003) The genetics of malignant melanoma: lessons from mouse and man. Nature reviews Cancer 3: 559–570.
- View Article
- Google Scholar
2. Woodhead AD, Setlow RB, Tanaka M (1999) Environmental factors in nonmelanoma and melanoma skin cancer. Journal of epidemiology Japan Epidemiological Association 9: S102–14.
- View Article
- Google Scholar
3. Carlson JA, Ross JS, Slominski A, Linette G, Mysliborski J, et al.. (2005) Molecular diagnostics in melanoma. Journal of the American Academy of Dermatology 52: : 743–775; quiz 775–778.
4. Fidler IJ (2002) Critical determinants of metastasis. Seminars in Cancer Biology 12: 89–96.
- View Article
- Google Scholar
5. Braeuer RR, Zigler M, Villares GJ, Dobroff AS, Bar-Eli M (2011) Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Seminars in Cancer Biology 21: 83–88.
- View Article
- Google Scholar
6. Young C (2009) Solar ultraviolet radiation and skin cancer. Occupational medicine Oxford England 59: 82–88.
- View Article
- Google Scholar
7. De Vries E, Arnold M, Altsitsiadis E, Trakatelli M, Hinrichs B, et al. (2012) Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010–2050. The British journal of dermatology 167 Suppl53–62.
- View Article
- Google Scholar
8. Poljšak B, Dahmane R (2012) Free radicals and extrinsic skin aging. Dermatology research and practice 2012: 135206.
- View Article
- Google Scholar
9. Cooper KL, Liu KJ, Hudson LG (2009) Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radical Biology & Medicine 47: 381–388.
- View Article
- Google Scholar
10. Darr D, Fridovich I (1994) Free radicals in cutaneous biology. The Journal of investigative dermatology 102: 671–675.
- View Article
- Google Scholar
11. Sies H (1991) Oxidative stress: from basic research to clinical application. The American Journal of Medicine 91: 31S–38S.
- View Article
- Google Scholar
12. Block K, Gorin Y (2012) Aiding and abetting roles of NOX oxidases in cellular transformation. Nature Reviews Cancer 12: 627–637.
- View Article
- Google Scholar
13. Luo H, Yang Y, Duan J, Wu P, Jiang Q, et al. (2013) PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells. Cell death disease 4: e481.
- View Article
- Google Scholar
14. Brieger K, Schiavone S, Miller FJ, Krause K-H (2012) Reactive oxygen species: from health to disease. Swiss medical weekly 142: w13659
- View Article
- Google Scholar
15. Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH oxidase. ArchBiochemBiophys 397: 342–344.
- View Article
- Google Scholar
16. Kleniewska P, Piechota A, Skibska B, Gorąca A (2012) The NADPH oxidase family and its inhibitors. Archivum Immunologiae et Therapiae Experimentalis 60: 277–294.
- View Article
- Google Scholar
17. Santos CXC, Anilkumar N, Zhang M, Brewer AC, Shah AM (2011) Redox signaling in cardiac myocytes. Free Radical Biology & Medicine 50: 777–793.
- View Article
- Google Scholar
18. Weaver JR, Taylor-Fishwick D (2013) Regulation of NOX-1 expression in beta cells: a positive feedback loop involving the Src-kinase signaling pathway. Molecular and cellular endocrinology 369: 35–41.
- View Article
- Google Scholar
19. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Research 51: 794–798.
- View Article
- Google Scholar
20. Mochizuki T, Furuta S, Mitsushita J, Shang WH, Ito M, et al. (2006) Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 25: 3699–3707.
- View Article
- Google Scholar
21. Hsieh C-H, Shyu W-C, Chiang C-Y, Kuo J-W, Shen W-C, et al. (2011) NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme. PLoS ONE 6: e23945
- View Article
- Google Scholar
22. Liu F, Gomez Garcia AM, Meyskens FL (2012) NADPH Oxidase 1 Overexpression Enhances Invasion via Matrix Metalloproteinase-2 and Epithelial-Mesenchymal Transition in Melanoma Cells. The Journal of investigative dermatology: 1–9.
23. Du J, Nelson ES, Simons AL, Olney KE, Moser JC, et al.. (2012) Regulation of pancreatic cancer growth by superoxide. Molecular Carcinogenesis.
24. Zhou X, Li D, Resnick MB, Behar J, Wands J, et al. (2011) Signaling in H2O2-induced increase in cell proliferation In Barrett's Esophageal Adenocarcinoma Cells. The Journal of pharmacology and experimental therapeutics 339: 218–227.
- View Article
- Google Scholar
25. Shono T, Yokoyama N, Uesaka T, Kuroda J, Takeya R, et al. (2008) Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. International journal of cancer Journal international du cancer 123: 787–792.
- View Article
- Google Scholar
26. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, et al. (2002) An NAD(P)H oxidase regulates growth and transcription in melanoma cells. American journal of physiology Cell physiology 282: C1212–24.
- View Article
- Google Scholar
27. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, et al. (2003) NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. American journal of physiology Cell physiology 285: C353–C369.
- View Article
- Google Scholar
28. van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, et al. (1991) Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. International journal of cancer Journal international du cancer 48: 85–91.
- View Article
- Google Scholar
29. Qin Y, Lu M, Gong X (2008) Dihydrorhodamine 123 is superior to 2,7-dichlorodihydrofluorescein diacetate and dihydrorhodamine 6G in detecting intracellular hydrogen peroxide in tumor cells. Cell Biol Int 32: 224–228.
- View Article
- Google Scholar
30. Fernandes DC, Wosniak J, Pescatore LA, Bertoline MA, Liberman M, et al. (2007) Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. American journal of physiology Cell physiology 292: C413–22.
- View Article
- Google Scholar
31. Van De Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RH, Langenhuijsen MM (1991) Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. Journal of Immunological Methods 141: 15–22.
- View Article
- Google Scholar
32. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochemical and biophysical research communications 197: 40–45.
- View Article
- Google Scholar
33. Dooley DC, Simpson JF, Meryman HT (1982) Isolation of large numbers of fully viable human neutrophils: a preparative technique using percoll density gradient centrifugation. Experimental Hematology 10: 591–599.
- View Article
- Google Scholar
34. Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, et al. (2008) Classical inhibitors of NOX NAD(P)H oxidases are not specific. Current Drug Metabolism 9: 686–696.
- View Article
- Google Scholar
35. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, et al. (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. The Journal of Cell Biology 161: 933–944.
- View Article
- Google Scholar
36. Chiarugi P (2005) PTPs versus PTKs: the redox side of the coin. Free Radical Research 39: 353–364.
- View Article
- Google Scholar
37. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signalling. Current Medicinal Chemistry 11: 1163–1182.
- View Article
- Google Scholar
38. Boonstra J, Post JA (2004) Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337: 1–13.
- View Article
- Google Scholar
39. Nogueira V, Park Y, Chen C-C, Xu P-Z, Chen M-L, et al. (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: 458–470.
- View Article
- Google Scholar
40. Afanas'ev I (2011) Reactive oxygen species signaling in cancer: comparison with aging. Aging and disease 2: 219–230.
- View Article
- Google Scholar
41. Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ (2004) Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. International Journal of Dermatology 43: 326–335.
- View Article
- Google Scholar
42. Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, et al. (2012) ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 31: 1117–1129.
- View Article
- Google Scholar
43. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemicobiological interactions 160: 1–40.
- View Article
- Google Scholar
44. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. The World Allergy Organization journal 5: 9–19
- View Article
- Google Scholar
45. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK (2008) Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype: 1777–1785.
46. Klees RF, De Marco PC, Salasznyk RM, Ahuja D, Hogg M, et al. (2006) Apocynin derivatives interrupt intracellular signaling resulting in decreased migration in breast cancer cells. Journal of biomedicine & biotechnology 2006: 87246.
- View Article
- Google Scholar
47. Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nature Reviews Drug Discovery 10: 453–471.
- View Article
- Google Scholar
48. Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, et al. (2009) NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Research 69: 2647–2654.
- View Article
- Google Scholar
49. Hehlgans S, Haase M, Cordes N (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochimica et Biophysica Acta 1775: 163–180.
- View Article
- Google Scholar
50. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. 6: 56–68.
- View Article
- Google Scholar
51. Van Nimwegen MJ, Van De Water B (2007) Focal adhesion kinase: A potential target in cancer therapy. 73: 597–609.
- View Article
- Google Scholar
52. Hess AR, Hendrix MJC (2006) Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell cycle Georgetown Tex 5: 478–480.
- View Article
- Google Scholar
53. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, et al. (1994) Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Molecular and Cellular Biology 14: 1680–1688.
- View Article
- Google Scholar
54. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology 18: 516–523.
- View Article
- Google Scholar
55. Ding Q, Grammer JR, Nelson M, Guan J-L, Stewart JE, et al. (2005) p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. The Journal of biological chemistry 280: 6802–6815.
- View Article
- Google Scholar
56. Beauséjour M, Noël D, Thibodeau S, Bouchard V, Harnois C, et al. (2012) Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis an international journal on programmed cell death 17: 566–578.
- View Article
- Google Scholar
57. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, et al. (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circulation Research 105: 249–259.
- View Article
- Google Scholar
58. Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13: 555–562.
- View Article
- Google Scholar
59. Zhong X, Rescorla FJ (2012) Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cellular Signalling 24: 393–401.
- View Article
- Google Scholar
60. Grossmann J (2002) Molecular mechanisms of “detachment-induced apoptosis—Anoikis”. Apoptosis an international journal on programmed cell death 7: 247–260.
- View Article
- Google Scholar
61. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surger 135: 555–562.
- View Article
- Google Scholar
62. Liu G, Meng X, Jin Y, Bai J, Zhao Y, et al. (2008) Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell biology international 32: 663–670.
- View Article
- Google Scholar
63. Pani G, Galeotti T, Chiarugi P (2010) Metastasis: cancer cell's escape from oxidative stress. Cancer metastasis reviews 29: 351–378.
- View Article
- Google Scholar
64. Giannoni E, Buricchi F, Grimaldi G, Parri M, Cialdai F, et al. (2008) Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death and Differentiation 15: 867–878.
- View Article
- Google Scholar
65. Giannoni E, Fiaschi T, Ramponi G, Chiarugi P (2009) Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28: 2074–2086.
- View Article
- Google Scholar

[ref1] 1. Chin L (2003) The genetics of malignant melanoma: lessons from mouse and man. Nature reviews Cancer 3: 559–570.
View Article
Google Scholar

[2] View Article

[3] Google Scholar

[ref2] 2. Woodhead AD, Setlow RB, Tanaka M (1999) Environmental factors in nonmelanoma and melanoma skin cancer. Journal of epidemiology Japan Epidemiological Association 9: S102–14.
View Article
Google Scholar

[5] View Article

[6] Google Scholar

[ref3] 3. Carlson JA, Ross JS, Slominski A, Linette G, Mysliborski J, et al.. (2005) Molecular diagnostics in melanoma. Journal of the American Academy of Dermatology 52: : 743–775; quiz 775–778.

[ref4] 4. Fidler IJ (2002) Critical determinants of metastasis. Seminars in Cancer Biology 12: 89–96.
View Article
Google Scholar

[9] View Article

[10] Google Scholar

[ref5] 5. Braeuer RR, Zigler M, Villares GJ, Dobroff AS, Bar-Eli M (2011) Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Seminars in Cancer Biology 21: 83–88.
View Article
Google Scholar

[12] View Article

[13] Google Scholar

[ref6] 6. Young C (2009) Solar ultraviolet radiation and skin cancer. Occupational medicine Oxford England 59: 82–88.
View Article
Google Scholar

[15] View Article

[16] Google Scholar

[ref7] 7. De Vries E, Arnold M, Altsitsiadis E, Trakatelli M, Hinrichs B, et al. (2012) Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010–2050. The British journal of dermatology 167 Suppl53–62.
View Article
Google Scholar

[18] View Article

[19] Google Scholar

[ref8] 8. Poljšak B, Dahmane R (2012) Free radicals and extrinsic skin aging. Dermatology research and practice 2012: 135206.
View Article
Google Scholar

[21] View Article

[22] Google Scholar

[ref9] 9. Cooper KL, Liu KJ, Hudson LG (2009) Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radical Biology & Medicine 47: 381–388.
View Article
Google Scholar

[24] View Article

[25] Google Scholar

[ref10] 10. Darr D, Fridovich I (1994) Free radicals in cutaneous biology. The Journal of investigative dermatology 102: 671–675.
View Article
Google Scholar

[27] View Article

[28] Google Scholar

[ref11] 11. Sies H (1991) Oxidative stress: from basic research to clinical application. The American Journal of Medicine 91: 31S–38S.
View Article
Google Scholar

[30] View Article

[31] Google Scholar

[ref12] 12. Block K, Gorin Y (2012) Aiding and abetting roles of NOX oxidases in cellular transformation. Nature Reviews Cancer 12: 627–637.
View Article
Google Scholar

[33] View Article

[34] Google Scholar

[ref13] 13. Luo H, Yang Y, Duan J, Wu P, Jiang Q, et al. (2013) PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells. Cell death disease 4: e481.
View Article
Google Scholar

[36] View Article

[37] Google Scholar

[ref14] 14. Brieger K, Schiavone S, Miller FJ, Krause K-H (2012) Reactive oxygen species: from health to disease. Swiss medical weekly 142: w13659
View Article
Google Scholar

[39] View Article

[40] Google Scholar

[ref15] 15. Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH oxidase. ArchBiochemBiophys 397: 342–344.
View Article
Google Scholar

[42] View Article

[43] Google Scholar

[ref16] 16. Kleniewska P, Piechota A, Skibska B, Gorąca A (2012) The NADPH oxidase family and its inhibitors. Archivum Immunologiae et Therapiae Experimentalis 60: 277–294.
View Article
Google Scholar

[45] View Article

[46] Google Scholar

[ref17] 17. Santos CXC, Anilkumar N, Zhang M, Brewer AC, Shah AM (2011) Redox signaling in cardiac myocytes. Free Radical Biology & Medicine 50: 777–793.
View Article
Google Scholar

[48] View Article

[49] Google Scholar

[ref18] 18. Weaver JR, Taylor-Fishwick D (2013) Regulation of NOX-1 expression in beta cells: a positive feedback loop involving the Src-kinase signaling pathway. Molecular and cellular endocrinology 369: 35–41.
View Article
Google Scholar

[51] View Article

[52] Google Scholar

[ref19] 19. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Research 51: 794–798.
View Article
Google Scholar

[54] View Article

[55] Google Scholar

[ref20] 20. Mochizuki T, Furuta S, Mitsushita J, Shang WH, Ito M, et al. (2006) Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 25: 3699–3707.
View Article
Google Scholar

[57] View Article

[58] Google Scholar

[ref21] 21. Hsieh C-H, Shyu W-C, Chiang C-Y, Kuo J-W, Shen W-C, et al. (2011) NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme. PLoS ONE 6: e23945
View Article
Google Scholar

[60] View Article

[61] Google Scholar

[ref22] 22. Liu F, Gomez Garcia AM, Meyskens FL (2012) NADPH Oxidase 1 Overexpression Enhances Invasion via Matrix Metalloproteinase-2 and Epithelial-Mesenchymal Transition in Melanoma Cells. The Journal of investigative dermatology: 1–9.

[ref23] 23. Du J, Nelson ES, Simons AL, Olney KE, Moser JC, et al.. (2012) Regulation of pancreatic cancer growth by superoxide. Molecular Carcinogenesis.

[ref24] 24. Zhou X, Li D, Resnick MB, Behar J, Wands J, et al. (2011) Signaling in H2O2-induced increase in cell proliferation In Barrett's Esophageal Adenocarcinoma Cells. The Journal of pharmacology and experimental therapeutics 339: 218–227.
View Article
Google Scholar

[65] View Article

[66] Google Scholar

[ref25] 25. Shono T, Yokoyama N, Uesaka T, Kuroda J, Takeya R, et al. (2008) Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. International journal of cancer Journal international du cancer 123: 787–792.
View Article
Google Scholar

[68] View Article

[69] Google Scholar

[ref26] 26. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, et al. (2002) An NAD(P)H oxidase regulates growth and transcription in melanoma cells. American journal of physiology Cell physiology 282: C1212–24.
View Article
Google Scholar

[71] View Article

[72] Google Scholar

[ref27] 27. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, et al. (2003) NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. American journal of physiology Cell physiology 285: C353–C369.
View Article
Google Scholar

[74] View Article

[75] Google Scholar

[ref28] 28. van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, et al. (1991) Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. International journal of cancer Journal international du cancer 48: 85–91.
View Article
Google Scholar

[77] View Article

[78] Google Scholar

[ref29] 29. Qin Y, Lu M, Gong X (2008) Dihydrorhodamine 123 is superior to 2,7-dichlorodihydrofluorescein diacetate and dihydrorhodamine 6G in detecting intracellular hydrogen peroxide in tumor cells. Cell Biol Int 32: 224–228.
View Article
Google Scholar

[80] View Article

[81] Google Scholar

[ref30] 30. Fernandes DC, Wosniak J, Pescatore LA, Bertoline MA, Liberman M, et al. (2007) Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. American journal of physiology Cell physiology 292: C413–22.
View Article
Google Scholar

[83] View Article

[84] Google Scholar

[ref31] 31. Van De Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RH, Langenhuijsen MM (1991) Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. Journal of Immunological Methods 141: 15–22.
View Article
Google Scholar

[86] View Article

[87] Google Scholar

[ref32] 32. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochemical and biophysical research communications 197: 40–45.
View Article
Google Scholar

[89] View Article

[90] Google Scholar

[ref33] 33. Dooley DC, Simpson JF, Meryman HT (1982) Isolation of large numbers of fully viable human neutrophils: a preparative technique using percoll density gradient centrifugation. Experimental Hematology 10: 591–599.
View Article
Google Scholar

[92] View Article

[93] Google Scholar

[ref34] 34. Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, et al. (2008) Classical inhibitors of NOX NAD(P)H oxidases are not specific. Current Drug Metabolism 9: 686–696.
View Article
Google Scholar

[95] View Article

[96] Google Scholar

[ref35] 35. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, et al. (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. The Journal of Cell Biology 161: 933–944.
View Article
Google Scholar

[98] View Article

[99] Google Scholar

[ref36] 36. Chiarugi P (2005) PTPs versus PTKs: the redox side of the coin. Free Radical Research 39: 353–364.
View Article
Google Scholar

[101] View Article

[102] Google Scholar

[ref37] 37. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signalling. Current Medicinal Chemistry 11: 1163–1182.
View Article
Google Scholar

[104] View Article

[105] Google Scholar

[ref38] 38. Boonstra J, Post JA (2004) Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337: 1–13.
View Article
Google Scholar

[107] View Article

[108] Google Scholar

[ref39] 39. Nogueira V, Park Y, Chen C-C, Xu P-Z, Chen M-L, et al. (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: 458–470.
View Article
Google Scholar

[110] View Article

[111] Google Scholar

[ref40] 40. Afanas'ev I (2011) Reactive oxygen species signaling in cancer: comparison with aging. Aging and disease 2: 219–230.
View Article
Google Scholar

[113] View Article

[114] Google Scholar

[ref41] 41. Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ (2004) Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. International Journal of Dermatology 43: 326–335.
View Article
Google Scholar

[116] View Article

[117] Google Scholar

[ref42] 42. Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, et al. (2012) ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 31: 1117–1129.
View Article
Google Scholar

[119] View Article

[120] Google Scholar

[ref43] 43. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemicobiological interactions 160: 1–40.
View Article
Google Scholar

[122] View Article

[123] Google Scholar

[ref44] 44. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. The World Allergy Organization journal 5: 9–19
View Article
Google Scholar

[125] View Article

[126] Google Scholar

[ref45] 45. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK (2008) Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype: 1777–1785.

[ref46] 46. Klees RF, De Marco PC, Salasznyk RM, Ahuja D, Hogg M, et al. (2006) Apocynin derivatives interrupt intracellular signaling resulting in decreased migration in breast cancer cells. Journal of biomedicine & biotechnology 2006: 87246.
View Article
Google Scholar

[129] View Article

[130] Google Scholar

[ref47] 47. Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nature Reviews Drug Discovery 10: 453–471.
View Article
Google Scholar

[132] View Article

[133] Google Scholar

[ref48] 48. Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, et al. (2009) NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Research 69: 2647–2654.
View Article
Google Scholar

[135] View Article

[136] Google Scholar

[ref49] 49. Hehlgans S, Haase M, Cordes N (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochimica et Biophysica Acta 1775: 163–180.
View Article
Google Scholar

[138] View Article

[139] Google Scholar

[ref50] 50. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. 6: 56–68.
View Article
Google Scholar

[141] View Article

[142] Google Scholar

[ref51] 51. Van Nimwegen MJ, Van De Water B (2007) Focal adhesion kinase: A potential target in cancer therapy. 73: 597–609.
View Article
Google Scholar

[144] View Article

[145] Google Scholar

[ref52] 52. Hess AR, Hendrix MJC (2006) Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell cycle Georgetown Tex 5: 478–480.
View Article
Google Scholar

[147] View Article

[148] Google Scholar

[ref53] 53. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, et al. (1994) Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Molecular and Cellular Biology 14: 1680–1688.
View Article
Google Scholar

[150] View Article

[151] Google Scholar

[ref54] 54. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology 18: 516–523.
View Article
Google Scholar

[153] View Article

[154] Google Scholar

[ref55] 55. Ding Q, Grammer JR, Nelson M, Guan J-L, Stewart JE, et al. (2005) p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. The Journal of biological chemistry 280: 6802–6815.
View Article
Google Scholar

[156] View Article

[157] Google Scholar

[ref56] 56. Beauséjour M, Noël D, Thibodeau S, Bouchard V, Harnois C, et al. (2012) Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis an international journal on programmed cell death 17: 566–578.
View Article
Google Scholar

[159] View Article

[160] Google Scholar

[ref57] 57. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, et al. (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circulation Research 105: 249–259.
View Article
Google Scholar

[162] View Article

[163] Google Scholar

[ref58] 58. Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13: 555–562.
View Article
Google Scholar

[165] View Article

[166] Google Scholar

[ref59] 59. Zhong X, Rescorla FJ (2012) Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cellular Signalling 24: 393–401.
View Article
Google Scholar

[168] View Article

[169] Google Scholar

[ref60] 60. Grossmann J (2002) Molecular mechanisms of “detachment-induced apoptosis—Anoikis”. Apoptosis an international journal on programmed cell death 7: 247–260.
View Article
Google Scholar

[171] View Article

[172] Google Scholar

[ref61] 61. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surger 135: 555–562.
View Article
Google Scholar

[174] View Article

[175] Google Scholar

[ref62] 62. Liu G, Meng X, Jin Y, Bai J, Zhao Y, et al. (2008) Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell biology international 32: 663–670.
View Article
Google Scholar

[177] View Article

[178] Google Scholar

[ref63] 63. Pani G, Galeotti T, Chiarugi P (2010) Metastasis: cancer cell's escape from oxidative stress. Cancer metastasis reviews 29: 351–378.
View Article
Google Scholar

[180] View Article

[181] Google Scholar

[ref64] 64. Giannoni E, Buricchi F, Grimaldi G, Parri M, Cialdai F, et al. (2008) Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death and Differentiation 15: 867–878.
View Article
Google Scholar

[183] View Article

[184] Google Scholar

[ref65] 65. Giannoni E, Fiaschi T, Ramponi G, Chiarugi P (2009) Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28: 2074–2086.
View Article
Google Scholar

[186] View Article

[187] Google Scholar

Figures

Abstract

Introduction

Material and Methods

Ethics Statement

Reagents

Cell Culture

Measurement of ROS generation in intact cells by DHR

Cellular ROS measurement by HPLC

Real-time intracellular ROS production

DAF-FM DA assay.

CM-H2DCF DA assay.

HPF assay.

Cell viability assays

MTT assay.

Sulforhodamine B assay.

Immunocytochemistry and cytochemistry assays

Apoptosis detection

Hypodiploid DNA content analysis.

Experiments using RNA interference

Assessment of mitochondrial transmembrane potential (JC-1)

Total cell extracts

Immunoprecipitation

Immunoblotting analysis

Isolation of human neutrophils

RNA isolation and RT-PCR

Statistical analysis

Results

Constitutive ROS generation by MV3 melanoma cells requires NADPH oxidase activity

NADPH oxidase-derived ROS are involved in MV3 melanoma cells survival

NADPH oxidase regulates focal adhesions and actin cytoskeleton dynamics in MV3 melanoma cells

FAKY397 phosphorylation and its association to cSrc requires NADPH oxidase activity

NADPH oxidase inhibition induces apoptosis in melanoma cells

NOX4 silencing diminishes phosphorylated FAK content and MV3 cell survival

Discussion

Supporting Information

Figure S1.

Figure S2.

Acknowledgments

Author Contributions

References

FAK^Y397 phosphorylation and its association to cSrc requires NADPH oxidase activity